417 related articles for article (PubMed ID: 28792932)
1. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA
Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O
Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932
[TBL] [Abstract][Full Text] [Related]
2. Non-Edg family LPA receptors: the cutting edge of LPA research.
Yanagida K; Ishii S
J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769
[TBL] [Abstract][Full Text] [Related]
3. Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: a homology modeling study.
Li G; Mosier PD; Fang X; Zhang Y
J Mol Graph Model; 2009 Aug; 28(1):70-9. PubMed ID: 19423373
[TBL] [Abstract][Full Text] [Related]
4. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
Noguchi K; Ishii S; Shimizu T
J Biol Chem; 2003 Jul; 278(28):25600-6. PubMed ID: 12724320
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid (LPA) signaling via LPA
Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
[TBL] [Abstract][Full Text] [Related]
6. Non-Edg family lysophosphatidic acid (LPA) receptors.
Ishii S; Noguchi K; Yanagida K
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):57-65. PubMed ID: 19524700
[TBL] [Abstract][Full Text] [Related]
7. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
[TBL] [Abstract][Full Text] [Related]
8. Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells.
Ren Y; Guo L; Tang X; Apparsundaram S; Kitson C; Deguzman J; Fuentes ME; Coyle L; Majmudar R; Allard J; Truitt T; Hamid R; Chen Y; Qian Y; Budd DC
Microvasc Res; 2013 Jan; 85():59-67. PubMed ID: 23084965
[TBL] [Abstract][Full Text] [Related]
9. The role of lysophosphatidic acid in the physiology and pathology of the skin.
Lei L; Su J; Chen J; Chen W; Chen X; Peng C
Life Sci; 2019 Mar; 220():194-200. PubMed ID: 30584899
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the binding mechanism of LPA species and analogs in an LPA
Wang H; Li M; St Onge CM; Fuss B; Zhang Y
J Mol Graph Model; 2022 Nov; 116():108274. PubMed ID: 35868118
[TBL] [Abstract][Full Text] [Related]
11. Current progress in non-Edg family LPA receptor research.
Yanagida K; Kurikawa Y; Shimizu T; Ishii S
Biochim Biophys Acta; 2013 Jan; 1831(1):33-41. PubMed ID: 22902318
[TBL] [Abstract][Full Text] [Related]
12. Two pathways for lysophosphatidic acid production.
Aoki J; Inoue A; Okudaira S
Biochim Biophys Acta; 2008 Sep; 1781(9):513-8. PubMed ID: 18621144
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Edg-Like LPA Receptor-Ligand Interactions.
Balogh B; Pazmany T; Matyus P
Curr Pharm Des; 2015; 21(24):3533-47. PubMed ID: 25686617
[TBL] [Abstract][Full Text] [Related]
14. Lateral access mechanism of LPA receptor probed by molecular dynamics simulation.
Suenaga R; Takemoto M; Inoue A; Ishitani R; Nureki O
PLoS One; 2022; 17(2):e0263296. PubMed ID: 35113924
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid-induced YAP/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4.
Yasuda D; Kobayashi D; Akahoshi N; Ohto-Nakanishi T; Yoshioka K; Takuwa Y; Mizuno S; Takahashi S; Ishii S
J Clin Invest; 2019 Jul; 129(10):4332-4349. PubMed ID: 31335323
[TBL] [Abstract][Full Text] [Related]
16. LPA(3), a unique G protein-coupled receptor for lysophosphatidic acid.
Hama K; Aoki J
Prog Lipid Res; 2010 Oct; 49(4):335-42. PubMed ID: 20230855
[TBL] [Abstract][Full Text] [Related]
17. Interaction between platelets and endothelial progenitor cells via LPA-Edg-2 axis is augmented by PPAR-δ activation.
Han JK; Kim BK; Won JY; Shin Y; Choi SB; Hwang I; Kang J; Lee HJ; Koh SJ; Lee J; Hur J; Cho HJ; Chae IH; Oh BH; Park YB; Kim HS
J Mol Cell Cardiol; 2016 Aug; 97():266-77. PubMed ID: 27266389
[TBL] [Abstract][Full Text] [Related]
18. Comparative analyses of lysophosphatidic acid receptor-mediated signaling.
Fukushima N; Ishii S; Tsujiuchi T; Kagawa N; Katoh K
Cell Mol Life Sci; 2015 Jun; 72(12):2377-94. PubMed ID: 25732591
[TBL] [Abstract][Full Text] [Related]
19. Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.
González de San Román E; Manuel I; Giralt MT; Chun J; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Ferrer I; Rodríguez-Puertas R
J Neurochem; 2015 Aug; 134(3):471-85. PubMed ID: 25857358
[TBL] [Abstract][Full Text] [Related]
20. Cell density-dependent expression of EDG family receptors and mesangial cell proliferation: role in lysophosphatidic acid-mediated cell growth.
Xing Y; Ganji SH; Noh JW; Kamanna VS
Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1250-7. PubMed ID: 15292052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]